Therapy of chronic delta hepatitis with alpha- and beta-interferon
Gaudin, J.L.; Trépo, C.
Progress in Clinical and Biological Research 382: 345-352
1993
ISSN/ISBN: 0361-7742 PMID: 8502701 Document Number: 414931
Document emailed within 1 workday
Related Documents
Di Bisceglie, A.M.; Negro, F.; Smedile, A.; Bergmann, K.; Hoofnagle, J.H. 1991: Alpha interferon therapy of chronic delta hepatitis: a pilot study Progress in Clinical and Biological Research 364: 393-397Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M. 1991: Long term treatment of chronic delta hepatitis with alpha recombinant interferon Progress in Clinical and Biological Research 364: 405-410
Gunsar, F.; Akarca, U.S.; Ersoz, G.; Kobak, A.C.; Karasu, Z.; Yuce, G.; Ilter, T.; Batur, Y. 2005: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis Antiviral Therapy 10(6): 721-726
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Di Marco, V.; Lo Iacono, O.; Capra, M.; Grutta, S.; Ciaccio, C.; Gerardi, C.; Maggio, A.; Renda, D.; Almasio, P.; Pisa, R. 1992: alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia Haematologica 77(6): 502-506
Fujisawa, T.; Inui, A.; Komatsu, H.; Miyagawa, Y.; Onoue, M. 1998: Interferon-alpha therapy for children with chronic hepatitis C Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 39(3): 146-149
Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G. 1993: Selection of patients with chronic hepatitis B for therapy with alpha-interferon Zeitschrift für Arztliche Fortbildung 87(4): 273-278
Alscher, D.M.; Bode, J.C. 1992: Therapy of acute and chronic viral hepatitis C (non-A, non-B) with interferon-alpha Medizinische Klinik 87(10): 532-539
Sampliner, R.E. 1991: Long-term effect of alpha-interferon therapy in chronic hepatitis B American Journal of Gastroenterology 86(12): 1838-1839
Mizoi, Y.; Kaneko, H.; Oharazawa, A.; Kuroiwa, H. 1997: Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C Rinsho Shinkeigaku 37(1): 54-56
Murata, K.; Shiraki, K.; Takase, K.; Nakano, T.; Tameda, Y. 2002: Mono-arthritis following intensified interferon beta therapy for chronic hepatitis C Hepato-Gastroenterology 49(47): 1418-1419
Panasiuk, A.; Prokopowicz, D.; Zak, J. 2004: Immunological response in chronic hepatitis C virus infection during interferon alpha therapy Hepato-Gastroenterology 51(58): 1088-1092
Bresci, G.; Parisi, G.; Banti, S.; Bertoni, M. 1993: Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up European Journal of Medicine 2(6): 349-352
Castilla, A.; Castilla, I.; Prieto, J. 1993: Alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia American Journal of Gastroenterology 88(3): 466-467
Orságová, I.; RoŽnovský, Lěk.; Petroušová, L.; Konečná, M.; Kabieszová, Lše.; Šafarčík, K.; Kloudová, A. 2014: Thyroid dysfunction during interferon alpha therapy for chronic hepatitis B and C - twenty years of experience Klinicka mikrobiologie a infekcni lekarstvi 20(3): 92-97
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Bolukbas, C.; Bolukbas, F.F.; Kebdir, T.; Canayaz, L.; Dalay, A.R.; Kilic, G.; Ovunc, O. 2005: Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature Acta Gastro-Enterologica Belgica 68(4): 432-434
Bernardinello, E.; Cavalletto, L.; Chemello, L.; Mezzocolli, I.; Donada, C.; Benvegnú, L.; Merkel, C.; Gatta, A.; Alberti, A. 1999: Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group Hepato-Gastroenterology 46(30): 3216-3222